During the last session, Geron Corp (NASDAQ:GERN)’s traded shares were 5.04 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $3.02, reflecting an intraday gain of 1.00% or $0.03. The 52-week high for the GERN share is $5.34, that puts it down -76.82 from that peak though still a striking 45.7% gain since the share price plummeted to a 52-week low of $1.64. The company’s market capitalization is $1.83B, and the average intraday trading volume over the past 10 days was 10.22 million shares, and the average trade volume was 10.31 million shares over the past three months.
Geron Corp (GERN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.11. GERN has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.05.
Geron Corp (NASDAQ:GERN) trade information
Geron Corp (GERN) registered a 1.00% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.00% in intraday trading to $3.02, hitting a weekly high. The stock’s 5-day price performance is 0.33%, and it has moved by -17.49% in 30 days. Based on these gigs, the overall price performance for the year is 59.79%. The short interest in Geron Corp (NASDAQ:GERN) is 65.07 million shares and it means that shorts have 5.7 day(s) to cover.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 56.86% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5.5 and $8 respectively. As a result, GERN is trading at a discount of -164.9% off the target high and -82.12% off the low.
Geron Corp (GERN) estimates and forecasts
Statistics show that Geron Corp has outperformed its competitors in share price, compared to the industry in which it operates. Geron Corp (GERN) shares have gone down -34.63% during the last six months, with a year-to-date growth rate more than the industry average at 18.75% against 16.50. In the rating firms’ projections, revenue will increase 37,898.68% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 59.01M as predicted by 8 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 54.71M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 23k and 304k respectively. In this case, analysts expect current quarter sales to grow by 256,447.83% and then jump by 17,896.84% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -16.08%. While earnings are projected to return 19.11% in 2025.
GERN Dividends
Geron Corp is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Geron Corp (NASDAQ:GERN)’s Major holders
Geron Corp insiders own 0.09% of total outstanding shares while institutional holders control 85.43%, with the float percentage being 85.50%. BLACKROCK INC. is the largest shareholder of the company, while 338.0 institutions own stock in it. As of 2024-06-30, the company held over 46.55 million shares (or 7.7138% of all shares), a total value of $197.38 million in shares.
The next largest institutional holding, with 46.2 million shares, is of RA CAPITAL MANAGEMENT, L.P.’s that is approximately 7.6558% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $195.9 million.
